Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 47
Filtrar
Más filtros

Medicinas Complementárias
Tipo del documento
Intervalo de año de publicación
1.
Public Health ; 190: 168-172, 2021 Jan.
Artículo en Inglés | MEDLINE | ID: mdl-33341278

RESUMEN

OBJECTIVES: Based on the legal framework regulating the advertisement of food supplements in the EU, the aim of this article is to analyse the relationship between the presence of endorsers, the different types of health-related claims (H-RCs) and product content information. STUDY DESIGN: We applied a quantitative approach based on the content analysis of all radio spots broadcast throughout 2017 on full-service radio stations in Spain. METHODS: A corpus of 10,556 radio spots was obtained of the three radio stations with the highest audience levels (165 without repetitions). We incorporated data on the accumulated broadcast frequencies to supplement the content analysis specific to each radio spot with its weight in relation to the overall advertising discourse. We developed a coding scheme to assess the type of endorser, the types of H-RCs, and the product content information. RESULTS: Results show that European directives are breached in different ways. Healthcare experts prevail in disease claims, although they are prohibited. Celebrities are the most widely used endorsers (25%) in the function and reduction of disease risk claims. In addition, although these types of claims require substantiation by authorised ingredient, 73% of H-RCs lack this information. CONCLUSIONS: The high presence of illicit H-RCs and endorsers, such as physicians, and the omission of compulsory product information suggest that public administrations must apply stricter monitoring and sanctioning mechanisms to dissuade advertisers from further breaches of the law and to protect consumers. Implications for public health policy are made.


Asunto(s)
Publicidad/legislación & jurisprudencia , Suplementos Dietéticos , Etiquetado de Alimentos/legislación & jurisprudencia , Alimentos/normas , Etiquetado de Productos/legislación & jurisprudencia , Publicidad/métodos , Humanos , Legislación Alimentaria , España
2.
J Law Health ; 33(1): 47-78, 2019.
Artículo en Inglés | MEDLINE | ID: mdl-31841617

RESUMEN

People are often looking for that quick fix when it comes to their health. With dietary supplements so readily available on the market, the public assume that they have been through rigorous testing. Dietary supplements are not tested as much as consumers believe. The Food and Drug Administration (FDA) does not initiate the same type of testing and analysis for supplements as it does for food, drink and medication. Given that people are now choosing supplemental meal replacements and the like, as opposed to whole foods, regulations drastically need to be stepped up in an effort to emphasise public safety. An authoritative body needs to stop manufacturers from taking advantage of an already vulnerable marketplace. I suggest a new form of regulation that takes the pressure away from the FDA and into the hands of someone who wholly focuses on the supplement market. Dietary supplements have revolutionised the "health" world; however, the only way that the market can keep growing is through enacting more stringent rules and regulations--at the same time allowing consumers to maintain their autonomy and freedom when purchasing.


Asunto(s)
Seguridad de Productos para el Consumidor/legislación & jurisprudencia , Suplementos Dietéticos/economía , Suplementos Dietéticos/normas , Regulación Gubernamental , Mercadotecnía/legislación & jurisprudencia , Etiquetado de Productos/legislación & jurisprudencia , Etiquetado de Productos/normas , Suplementos Dietéticos/efectos adversos , Legislación Alimentaria/tendencias , Estados Unidos , United States Federal Trade Commission , United States Food and Drug Administration
3.
Rev Saude Publica ; 53: 90, 2019.
Artículo en Inglés, Portugués | MEDLINE | ID: mdl-31644771

RESUMEN

OBJECTIVE: The new regulatory framework for dietary supplements in Brazil prompted this analysis of the current outlook of these products and the challenges posed by the new guidelines. METHODS: We conducted a qualitative, observational and descriptive study of dietary supplements commercialized in Brazilian online stores with the help of the Google® search tool. We considered the ingredients on the labels, the effects attributed to these products and the commercial claims used as a means of promoting them to assess the necessary changes for the legal framework in the new guidelines. Finally, with the help of a database, we compared the effects declared by the manufacturers and attributed to certain ingredients with the scientific evidence described in literature. RESULTS: In total, we purchased 44 dietary supplements from Brazilian online stores (n = 7). Of the samples studied, 34.2% could not be classified in the category Dietary Supplements, as recommended by the new regulation of the Brazilian Health Regulatory Agency due to the presence of prohibited substances; 16% of products should be commercialized as medicines. Regarding the commercial appeals, 97.7% had banned expressions. Numerous claims of effects attributed to certain products were characterized as consumer fraud because they have no scientific evidence. CONCLUSIONS: The necessary changes represent a major regulatory and production challenge due to the wide range of dietary supplements and markets, an effort that aims to protect the consumers' health. Some previous gaps in the regulatory framework were not fully solved.


Asunto(s)
Comercio/legislación & jurisprudencia , Suplementos Dietéticos , Etiquetado de Productos/legislación & jurisprudencia , Brasil , Comercio/normas , Suplementos Dietéticos/normas , Ingredientes Alimentarios/normas , Humanos , Legislación Alimentaria/normas , Etiquetado de Productos/normas , Salud Pública , Investigación Cualitativa
4.
Drug Alcohol Depend ; 198: 87-94, 2019 05 01.
Artículo en Inglés | MEDLINE | ID: mdl-30889524

RESUMEN

INTRODUCTION: Legal challenges have blocked the implementation of large, pictorial health warning labels (HWLs) in the U.S. In light of future legal questions the U.S. Food and Drug Administration may face in proposing alternative HWLs, we examined whether less restrictive HWL versions on the front of packs-smaller HWLs and/or text-only HWLs that do not include pictorial imagery-may be sufficient to promote cognitive and affective outcomes associated with smoking cessation. METHODS: We recruited low-income smokers in two separate experiments through field-based recruitment methods (Study 1, N = 497) or Amazon Mechanical Turk (MTurk) (Study 2, N = 495). In both studies, we randomly assigned participants to a no-HWL control condition or one of four HWL conditions in a 2 (pictorial vs. text-only) × 2 (50% vs. 30% size) between-subjects design. RESULTS: Relative to text-only HWLs, pictorial HWLs increased negative affect but not risk belief acceptance, cognitive elaboration about smoking harms, or quit intentions. The 50% HWLs increased quit intentions relative to the control condition in both studies. The 50% HWLs also outperformed the 30% HWLs in promoting quit intentions in Study 2. Subsequent analyses revealed that this effect in Study 2 may have been driven by the 50% HWLs strengthening the relationship between risk-related thoughts and intentions, although there was no evidence for this pattern in Study 1. We found no evidence for interaction effects between the pictorial and size manipulations. CONCLUSIONS: Our findings suggest that 50% HWLs, whether pictorial or text-only, can encourage low-income smokers to consider quitting under some conditions.


Asunto(s)
Etiquetado de Productos/métodos , Fumadores/psicología , Cese del Hábito de Fumar/psicología , Productos de Tabaco/provisión & distribución , Fumar Tabaco/psicología , Adulto , Recursos Audiovisuales , Femenino , Humanos , Intención , Masculino , Pobreza/psicología , Etiquetado de Productos/legislación & jurisprudencia , Productos de Tabaco/legislación & jurisprudencia , Fumar Tabaco/legislación & jurisprudencia , Estados Unidos , United States Food and Drug Administration
5.
Rev. saúde pública (Online) ; 53: 90, jan. 2019. tab, graf
Artículo en Inglés | LILACS | ID: biblio-1043340

RESUMEN

ABSTRACT OBJECTIVE The new regulatory framework for dietary supplements in Brazil prompted this analysis of the current outlook of these products and the challenges posed by the new guidelines. METHODS We conducted a qualitative, observational and descriptive study of dietary supplements commercialized in Brazilian online stores with the help of the Google® search tool. We considered the ingredients on the labels, the effects attributed to these products and the commercial claims used as a means of promoting them to assess the necessary changes for the legal framework in the new guidelines. Finally, with the help of a database, we compared the effects declared by the manufacturers and attributed to certain ingredients with the scientific evidence described in literature. RESULTS In total, we purchased 44 dietary supplements from Brazilian online stores (n = 7). Of the samples studied, 34.2% could not be classified in the category Dietary Supplements, as recommended by the new regulation of the Brazilian Health Regulatory Agency due to the presence of prohibited substances; 16% of products should be commercialized as medicines. Regarding the commercial appeals, 97.7% had banned expressions. Numerous claims of effects attributed to certain products were characterized as consumer fraud because they have no scientific evidence. CONCLUSIONS The necessary changes represent a major regulatory and production challenge due to the wide range of dietary supplements and markets, an effort that aims to protect the consumers' health. Some previous gaps in the regulatory framework were not fully solved.


RESUMO OBJETIVO O novo marco regulatório para os suplementos alimentares no Brasil instigou a presente análise do panorama atual desses produtos e os desafios impostos pelas novas diretrizes. MÉTODOS Foi realizado um estudo qualitativo, observacional e descritivo dos suplementos alimentares comercializados em lojas virtuais brasileiras, com o auxílio da ferramenta de busca Google®. Os ingredientes declarados nos rótulos, bem como os efeitos atribuídos a esses produtos e as alegações comerciais utilizadas como forma de promovê-los foram levados em consideração a fim de avaliarmos as mudanças necessárias para o enquadramento legal nas novas diretrizes. Por fim, com o auxílio de base de dados, foram comparados os efeitos declarados pelos fabricantes e atribuídos a determinados ingredientes com as evidências científicas descritas na literatura. RESULTADOS No total, foram adquiridos 44 suplementos alimentares provenientes de lojas virtuais brasileiras (n = 7). Das amostras estudadas, 34,2% não poderiam ser enquadradas na categoria Suplementos Alimentares, conforme preconiza a nova regulação da Agência Nacional de Vigilância Sanitária, em decorrência de presença de substâncias não permitidas; 16% dos produtos deveriam ser comercializados como medicamentos. Quanto aos apelos comerciais, 97,7% apresentavam expressões não permitidas. Inúmeras alegações de efeitos atribuídos a determinados produtos, por não possuírem comprovação científica, foram caracterizadas como fraude contra o consumidor. CONCLUSÕES Dada a extensa gama de suplementos alimentares e pontos de comercialização, as mudanças necessárias representam um grande desafio regulatório e de produção, esforço este que visa a proteger a saúde dos consumidores. Algumas lacunas previamente existentes ao marco regulatório ainda não foram totalmente solucionadas.


Asunto(s)
Humanos , Etiquetado de Productos/legislación & jurisprudencia , Comercio/legislación & jurisprudencia , Suplementos Dietéticos/normas , Etiquetado de Productos/normas , Brasil , Salud Pública , Comercio/normas , Investigación Cualitativa , Ingredientes Alimentarios/normas , Legislación Alimentaria/normas
6.
BMJ Open ; 8(7): e021983, 2018 07 13.
Artículo en Inglés | MEDLINE | ID: mdl-30007932

RESUMEN

OBJECTIVE: This study examined smokers' responses to pictorial health warnings (PHWs) with different types of imagery under natural exposure conditions. METHODS: Adult smokers from online panels in Canada (n=2357), Australia (n=1671) and Mexico (n=2537) were surveyed every 4 months from 2012 to 2013. Participants were shown PHWs on packs in their respective countries and asked about: (1) noticing PHWs; (2) negative affects towards PHWs; (3) believability of PHWs; (4) PHW-stimulated discussions; and (5) quit motivation due to PHWs. Country-specific generalised estimating equation models regressed these outcomes on time (ie, survey wave), PHW imagery type (ie, symbolic representations of risk, suffering from smoking and graphic depictions of bodily harm) and interactions between them. RESULTS: In all countries, PHW responses did not significantly change over time, except for increased noticing PHWs in Canada and Mexico, increased negative affect in Australia and decreased negative affect in Mexico. For all outcomes, symbolic PHWs were rated lower than suffering and graphic PHWs in Canada (the only country with symbolic PHWs). Graphic PHWs were rated higher than suffering PHWs for negative affect (all countries), discussions (Canada) and quit motivation (Australia). Suffering PHWs were rated higher than graphic PHWs for noticing PHWs (Canada), believability (all countries), discussions (AustraliaandMexico) and quit motivation (Mexico). Changes in noticing, believability and discussions varied somewhat by imagery type across countries. CONCLUSIONS: The different PHW imagery appears to have different pathways of influence on adult smokers. Reactions to specific PHWs are similar over 1-2 years, suggesting that wear-out of PHW effects is due to decreased attention rather than the diminishing effectiveness of content.


Asunto(s)
Seguridad de Productos para el Consumidor/legislación & jurisprudencia , Imágenes en Psicoterapia , Etiquetado de Productos/estadística & datos numéricos , Fumadores/psicología , Cese del Hábito de Fumar/métodos , Fumar/epidemiología , Fumar/psicología , Adulto , Australia/epidemiología , Canadá/epidemiología , Emociones , Femenino , Promoción de la Salud , Humanos , Imágenes en Psicoterapia/estadística & datos numéricos , Estudios Longitudinales , Masculino , México/epidemiología , Persona de Mediana Edad , Motivación , Etiquetado de Productos/legislación & jurisprudencia , Cese del Hábito de Fumar/psicología , Adulto Joven
10.
Am J Law Med ; 42(1): 53-84, 2016.
Artículo en Inglés | MEDLINE | ID: mdl-27263263

RESUMEN

This Article offers a thorough analysis of an important public health issue, namely how to confront the growing problem of deceptive claims regarding foods and dietary supplements, including increasingly prevalent but unverifiable claims. The authors call for the creation of a limited private right of action under the Federal Trade Commission (FTC) Act for deceptive health-related claims for these products. The proposal responds to the growing market for these products and the inadequacy of current laws and enforcement actions to prevent such claims. In crafting the limited private right of action, the authors attempt to enhance consumer protection without undermining federal agency primacy in enforcement. The Article ends with an appendix setting forth proposed language for a statutory amendment to the FTC Act incorporating the authors' proposal.


Asunto(s)
Publicidad/legislación & jurisprudencia , Seguridad de Productos para el Consumidor/legislación & jurisprudencia , Suplementos Dietéticos , Legislación Alimentaria , Humanos , Responsabilidad Legal , Etiquetado de Productos/legislación & jurisprudencia , Estados Unidos , United States Federal Trade Commission
11.
Can J Public Health ; 107(1): e133-e135, 2016 06 27.
Artículo en Inglés | MEDLINE | ID: mdl-27348101

RESUMEN

In 2012, Health Canada transitioned caffeinated energy drinks from Natural Health Product to Food and Drug classification and regulations, implementing temporary guidelines with requirements such as caffeine content limits, mandatory cautionary labelling, and restrictions on health claims. "Energy shots" often contain as much or more caffeine compared to energy drinks and have been associated with a similar number of adverse health events. However, current requirements for energy drinks do not apply to energy shots, which remain classified as "natural health products" on the basis that they are "not consumed or perceived as foods" in the same way as energy drinks. An online survey was conducted with Canadian youth and young adults aged 12-24 years (N = 2040) in October 2014 to examine perceptions of energy shots. Respondents viewed an image of a popular energy shot and were asked which term best described it, with six randomly-ordered options. The vast majority (78.8%) perceived the energy shot as an "energy drink" (vs. "supplement", "vitamin drink", "natural health product", "soft drink" or "food product"). Given consumer perceptions and the similarity in product constituents, there is little basis for regulating energy shots differently from energy drinks; these products should be subject to similar labelling and health warning requirements.


Asunto(s)
Cafeína/análisis , Bebidas Energéticas , Política de Salud , Etiquetado de Productos/legislación & jurisprudencia , Adolescente , Canadá , Niño , Humanos , Encuestas y Cuestionarios , Adulto Joven
12.
Chemosphere ; 152: 353-9, 2016 Jun.
Artículo en Inglés | MEDLINE | ID: mdl-26991383

RESUMEN

In response to concerns regarding the widespread use of flame retardants, the California Legislature passed a law (SB1019) requiring labels on furniture products to indicate whether they do or do not contain flame retardants. To support the enforcement of the new law, our laboratory developed a step-wise, screening approach to test for brominated (BFR) and phosphorus-based flame retardants (OPFRs) in several types of furniture components (foam, fabric, batting, plumage, etc.). We used X-Ray Fluorescence (XRF) to screen for the presence of Br (and other elements) and Inductively Coupled Plasma - Optical Emission Spectrometry (ICP-OES) to identify and measure the concentration of P (and other elements). The same samples were also extracted by dichloromethane using sonication and analyzed by a single injection into a Gas Chromatograph - Tandem Mass Spectrometer to obtain concentrations of specific BFRs and OPFRs. Our approach showed excellent screening potential for Br and Sb by XRF and for P by ICP-OES, with both tests having predictive values of a negative equal to 1. To explore and screen for flame retardants in products not included in our current list of target chemicals, we used Liquid Chromatography/Time-of-Flight Mass Spectrometry operated with electrospray ionization, to identify additional flame retardants to be incorporated in quantitative methods. We are making all our methodologies public to facilitate simple and low cost methods that can help manufacturers and suppliers have their products tested and correctly labeled, ultimately benefitting the consumer.


Asunto(s)
Retardadores de Llama/análisis , Diseño Interior y Mobiliario , Antimonio/análisis , Bromo/análisis , California , Cromatografía Liquida , Seguridad de Productos para el Consumidor/legislación & jurisprudencia , Cromatografía de Gases y Espectrometría de Masas , Diseño Interior y Mobiliario/legislación & jurisprudencia , Fósforo/análisis , Etiquetado de Productos/legislación & jurisprudencia , Espectrometría de Masas en Tándem , Rayos X
13.
Drug Test Anal ; 8(3-4): 402-6, 2016.
Artículo en Inglés | MEDLINE | ID: mdl-26594006

RESUMEN

Federal regulation of dietary supplements in the United States is governed by the Dietary Supplement Health and Education Act of 1994. The law has been criticized as weak and ineffective. Alarming research has emerged demonstrating that supplements may be mislabelled, contaminated, adulterated with dangerous or unknown compounds, or sold at toxic doses. As a result, the health community has raised concerns about the safety and quality of dietary supplements. Increased federal oversight is an important avenue for improving supplement safety; however, states and local governments may also pursue strategies to strengthen the overall regulatory control of dietary supplements. States and local governments have substantial experience in regulating other products that pose a risk to public health, such as tobacco. Additionally, much has been learned about the tactics the tobacco industry has employed to protect its interests. Lessons learned may be applied to new regulatory efforts aimed at improving the safety of dietary supplements at the state and local levels. Copyright © 2015 John Wiley & Sons, Ltd.


Asunto(s)
Suplementos Dietéticos/normas , Contaminación de Medicamentos/legislación & jurisprudencia , Legislación Alimentaria , Etiquetado de Productos/legislación & jurisprudencia , Regulación Gubernamental , Humanos , Gobierno Local , Gobierno Estatal , Estados Unidos
14.
State Legis ; 41(3): 25, 2015 Mar.
Artículo en Inglés | MEDLINE | ID: mdl-25946754

RESUMEN

Tim Cullen is CEO and founder of the Colorado Harvest Company and Evergreen Apothecary, an expanding business in Denver that grows and sells marijuana. His most lucrative store averages 200 to 300 sales a day, with roughly 80 percent being for recreational purposes. The former high school biology teacher became interested in marijuana when he saw how it helped his father control the pain and nausea of Crohn's Disease, which Cullen himself developed later. He began growing marijuana in his basement in Colorado, where growing medical marijuana for personal use has been legal for 12 years. He now grows his plants in 55,000 square feet in four warehouses.


Asunto(s)
Cannabis , Comercio/legislación & jurisprudencia , Drogas Ilícitas/legislación & jurisprudencia , Fitoterapia , Plantas Medicinales , Colorado , Humanos , Fumar Marihuana/legislación & jurisprudencia , Marihuana Medicinal , Etiquetado de Productos/legislación & jurisprudencia
15.
Regul Toxicol Pharmacol ; 67(3): 409-20, 2013 Dec.
Artículo en Inglés | MEDLINE | ID: mdl-24025648

RESUMEN

The process streams refined from petroleum crude oil for use in petroleum products are among those designated by USEPA as UVCB substances (unknown or variable composition, complex reaction products and biological materials). They are identified on global chemical inventories with unique Chemical Abstract Services (CAS) numbers and names. The chemical complexity of most petroleum substances presents challenges when evaluating their hazards and can result in differing evaluations due to the varying level of hazardous constituents and differences in national chemical control regulations. Global efforts to harmonize the identification of chemical hazards are aimed at promoting the use of consistent hazard evaluation criteria. This paper discusses a systematic approach for the health hazard evaluation of petroleum substances using chemical categories and the United Nations (UN) Globally Harmonized System (GHS) of classification and labeling. Also described are historical efforts to characterize the hazard of these substances and how they led to the development of categories, the identification of potentially hazardous constituents which should be considered, and a summary of the toxicology of the major petroleum product groups. The use of these categories can increase the utility of existing data, provide better informed hazard evaluations, and reduce the amount of animal testing required.


Asunto(s)
Sustancias Peligrosas/química , Sustancias Peligrosas/clasificación , Petróleo/clasificación , Animales , Unión Europea , Regulación Gubernamental , Sustancias Peligrosas/toxicidad , Petróleo/toxicidad , Etiquetado de Productos/legislación & jurisprudencia , Etiquetado de Productos/métodos , Etiquetado de Productos/normas , Estados Unidos
18.
S Afr Med J ; 101(8): 543-5, 2011 Jul 25.
Artículo en Inglés | MEDLINE | ID: mdl-21920129

RESUMEN

BACKGROUND. There is no clear distinction between the regulation of food, supplements and medicines in South Africa. Consequently, grey areas exist in implementing the legislation, particularly in the supplement industry. The increase in supplement sales in South Africa can be attributed to aggressive marketing by manufacturers whose claims are not always supported by published peer-reviewed evidence. Such claims often go unchecked, resulting in consumers being mislead about the role of supplements. As a result of poor regulation, contaminants or adulterants in supplements may also cause insidious effects unrelated to the listed ingredients. AIM. To assess the regulations, legislation, and claims associated with nutritional supplement products in South Africa. METHOD. Peer-reviewed literature and the relevant South African statutes were consulted. RESULTS. The National Health Act incorporates the Medicine Control Council, which is charged with ensuring the safety, quality and effectiveness of medicines, and related matters, including complementary/alternative medicines. The South African Institute for Drug-Free Sport and Amendment Act provides for testing athletes for using banned substances, but currently does not concern itself with monitoring nutritional supplements for contaminants or adulterants that may cause a positive drug test, which has implications for sports participants and also the health of the general population. The implementation of the Consumer Protection Act 68 of 2008 (CPA) could protect consumer rights if it is administered and resourced appropriately. CONCLUSION. The CPA should promote greater levels of policy development, regulatory enforcement, and consumer education of South Africa's supplement industry.


Asunto(s)
Seguridad de Productos para el Consumidor/legislación & jurisprudencia , Suplementos Dietéticos , Humanos , Mercadotecnía/legislación & jurisprudencia , Etiquetado de Productos/legislación & jurisprudencia , Sudáfrica
20.
Food Drug Law J ; 64(1): 43-67, 2009.
Artículo en Inglés | MEDLINE | ID: mdl-19998572

RESUMEN

Whether labeling and advertising claims for multi-ingredient dietary supplements may be based on the testing of individual, key ingredients--rather than the actual product--has caused a good deal of confusion. This confusion stems from the dearth of case law and the open-endedness of Federal Trade Commission (FTC) and Food and Drug Administration (FDA) guidance on this issue. Nevertheless, the relevant regulatory guidance, case law and self-regulatory case law--when assessed together--indicate that the law allows and even protects "key ingredient claims" (i.e., claims based on efficacy testing of key ingredients in the absence of full product testing). This article provides an overview of the relevant substantiation requirements for dietary supplement claims and then reviews FTC's and FDA's guidance on key ingredient claims; relevant case law; use of key ingredient claims in the advertising of other consumer products; and the National Advertising Division of the Better Business Bureau, Inc.'s (NAD's) approach to evaluating key ingredient claims for dietary supplements. This article concludes that key ingredient claims--provided they are presented in a truthful and non-deceptive manner--are permissible, and should be upheld in litigation and cases subject to industry self-regulation. This article further concludes that the NAD's approach to key ingredient claims provides practical guidance for crafting and substantiating dietary supplement key ingredient claims.


Asunto(s)
Publicidad/legislación & jurisprudencia , Suplementos Dietéticos , Etiquetado de Medicamentos/legislación & jurisprudencia , Etiquetado de Productos/legislación & jurisprudencia , Ensayos Clínicos como Asunto , Fraude , Humanos , Estados Unidos , United States Federal Trade Commission , United States Food and Drug Administration
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA